Maraviroc Attenuates Neuronal Apoptosis by Inhibiting CCR5-Mediated Microglial Activation After Subarachnoid Hemorrhage
Neurochemical Research · 2026-06 · 51 (3)
DOI: 10.1007/s11064-026-04779-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 20.05.2026. Verfasst von Jiasen Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, NO. 25 of Taiping Street, Luzhou, 646000, Sichuan, China. Hauptthemen laut MEDLINE: Maraviroc, Microglia, Subarachnoid Hemorrhage, Receptors, CCR5. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Subarachnoid hemorrhage (SAH) triggers robust neuroinflammatory responses that contribute to secondary brain injury, with microglia acting as central mediators; however, the upstream regulators governing microglial activation remain incompletely understood. To address this, we investigated the role of C-C chemokine receptor 5 (CCR5) using a murine endovascular perforation SAH model. Expression profiling revealed that CCR5 is rapidly upregulated after SAH, with prominent expression in microglia in the cortex and perilesional region. We then evaluated the therapeutic efficacy of pharmacological inhibition using the intranasal CCR5 antagonist maraviroc (MVC). MVC treatment successfully shifted microglia toward an anti-inflammatory phenotype and reduced pro-inflammatory cytokines. This inflammatory modulation attenuated brain edema, suppressed neuronal apoptosis, and significantly improved both early and long-term neurological outcomes. Furthermore, in vitro experiments confirmed that MVC reverses oxyhemoglobin-induced pro-inflammatory microglial polarization, indirectly protecting neurons from microglia-dependent injury. Collectively, these findings identify CCR5 as an important regulator of microglia-associated neuroinflammation after SAH and suggest that MVC exerts neuroprotection, at least in part, through modulation of the CCR5-related inflammatory microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, NO. 25 of Taiping Street, Luzhou, 646000, Sichuan, China.
- Laboratory of Neurological Diseases and Brain Function, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
- Sichuan Clinical Research Center for Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
- Institute of Brain Science, Southwest Medical University, Luzhou, 646000, Sichuan, China.
- Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, NO. 25 of Taiping Street, Luzhou, 646000, Sichuan, China. tutianqineurosci@sina.com.
- Laboratory of Neurological Diseases and Brain Function, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China. tutianqineurosci@sina.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, J., Li, H., Peng, Z., Duan, Z., Chen, Q., Jiang, Y., Tu, T., & Peng, J. (2026). Maraviroc Attenuates Neuronal Apoptosis by Inhibiting CCR5-Mediated Microglial Activation After Subarachnoid Hemorrhage. Neurochemical Research, 51(3). https://doi.org/10.1007/s11064-026-04779-7
Vancouver
Ye J, Li H, Peng Z, Duan Z, Chen Q, Jiang Y, et al. Maraviroc Attenuates Neuronal Apoptosis by Inhibiting CCR5-Mediated Microglial Activation After Subarachnoid Hemorrhage. Neurochemical Research. 2026;51(3). doi:10.1007/s11064-026-04779-7
BibTeX
@article{Ye2026,
author = {Ye, Jiasen and Li, Hangyang and Peng, Zhenghong and Duan, Zuoyue and Chen, Qiang and Jiang, Yong and Tu, Tianqi and Peng, Jianhua},
title = {Maraviroc Attenuates Neuronal Apoptosis by Inhibiting CCR5-Mediated Microglial Activation After Subarachnoid Hemorrhage},
journal = {Neurochemical Research},
year = {2026},
volume = {51},
number = {3},
doi = {10.1007/s11064-026-04779-7}
}
EUVIMED